MARKET INSIGHTS
Global Ammoniated Glycyrrhizin market was valued at USD 150 million in 2024 and is projected to reach USD 240 million by 2032, exhibiting a Compound Annual Growth Rate (CAGR) of 6% during the forecast period (2025–2032). The market is expected to expand due to increasing demand in food & beverage, pharmaceutical, and cosmetic industries.
Ammoniated Glycyrrhizin, a derivative of glycyrrhizic acid, is widely used as a natural sweetener and flavor enhancer. It is derived from licorice root and is known for its anti‑inflammatory and antioxidant properties. The compound is commonly utilized in food products, beverages, pharmaceuticals, and cosmetics due to its ability to enhance sweetness while reducing sugar content.
Key factors driving market growth include rising consumer preference for natural sweeteners, increasing health awareness, and stringent regulations on artificial additives. The pharmaceutical sector is also contributing to demand, as Ammoniated Glycyrrhizin is used in cough syrups and anti‑inflammatory medications. Leading companies such as Ruihong Bio‑technique, ELION Group, and Hunan Dinuo Pharmaceutical are actively expanding their production capacities to meet growing market needs.
Global Ammoniated Glycyrrhizin Market – View in Detailed Research Report
10. Ruihong Bio‑technique
Headquarters: Shandong, China
Key Offering: Pharmaceutical‑grade ammoniated glycyrrhizin, food‑grade sweetener, and cosmetic‑grade extracts
Ruihong has positioned itself as a major supplier in Asia‑Pacific, leveraging a vertically integrated chain that spans cultivation, extraction, and GMP‑certified processing. The company’s emphasis on purity has secured contracts with leading pharmaceutical formulators seeking consistent API performance.
Sustainability & Growth Initiatives:
- Investment in water‑recycling extraction units to reduce solvent use by 25%
- Partnerships with local farmers to promote sustainable licorice cultivation and secure a stable raw‑material supply
- Expansion of a new 200‑t annual capacity plant in 2025 to capture the rising demand in the cosmetic segment
9. ELION Group
Headquarters: Beijing, China
Key Offering: High‑purity pharmaceutical API, food‑grade sweetener, and specialty flavor enhancers
ELION’s R&D focus on bio‑purification techniques has allowed it to achieve the lowest impurity thresholds in the market, a critical factor for regulatory approval in the EU and US. The firm’s recent collaboration with a European pharmaceutical conglomerate has broadened its footprint across Western markets.
Sustainability & Growth Initiatives:
- Deployment of a closed‑loop CO₂ extraction system to cut greenhouse gas emissions by 18%
- Strategic alliance with a leading Chinese dairy brand to supply a natural sweetener line for organic products
- Projected 15% increase in annual sales volume through 2027 driven by the clean‑label trend
8. Hunan Dinuo Pharmaceutical
Headquarters: Changsha, China
Key Offering: Pharmaceutical‑grade API, functional food additives, and herbal medicine excipients
Hunan Dinuo’s integration of traditional Chinese medicine (TCM) expertise with modern pharmaceutical manufacturing has positioned it as a preferred supplier for cough syrups and anti‑inflammatory formulations across Asia.
Sustainability & Growth Initiatives:
- Launch of a new 150‑t production line dedicated to pharmaceutical‑grade API in 2024
- Adoption of a digital traceability platform to ensure raw‑material provenance and compliance with international standards
- Targeted expansion into the Indian market through joint ventures with local nutraceutical firms
7. Minophagen Pharmaceutical
Headquarters: Tokyo, Japan
Key Offering: High‑purity API, functional food sweeteners, and cosmeceutical ingredients
Minophagen’s focus on precision extraction and rigorous quality controls has made it a trusted partner for Japanese and Korean pharmaceutical companies seeking reliable supply of ammoniated glycyrrhizin.
Sustainability & Growth Initiatives:
- Implementation of a zero‑liquid‑waste policy in its extraction facilities
- Collaboration with a Japanese university to develop next‑generation bio‑synthesised glycyrrhizin derivatives
- Strategic investment in a 50‑t annual capacity plant to support the growing demand for natural sweeteners in East Asia
6. Xinjiang TIANSHAN Pharmaceutical
Headquarters: Urumqi, China
Key Offering: Pharmaceutical‑grade API, food‑grade sweetener, and specialty flavor compounds
With a strong foothold in the TCM market, Xinjiang TIANSHAN has capitalized on the region’s abundant licorice cultivation to secure a stable supply chain and reduce production costs.
Sustainability & Growth Initiatives:
- Adoption of renewable energy sources for 30% of plant operations
- Launch of a certification program for organic licorice cultivation in partnership with local farmers
- Expansion of export operations to Southeast Asia, targeting a 20% increase in foreign sales by 2028
5. Alps Pharmaceutical
Headquarters: Osaka, Japan
Key Offering: Pharmaceutical‑grade API, functional food additives, and cosmetic ingredients
Alps has distinguished itself through a focus on high‑purity production and compliance with stringent European regulations, enabling it to supply the growing European market for natural sweeteners.
Sustainability & Growth Initiatives:
- Integration of a closed‑loop water system to reduce water consumption by 22%
- Partnership with a leading EU cosmetic brand to develop a natural brightening line featuring ammoniated glycyrrhizin
- Investment in a 100‑t annual capacity expansion to meet the projected demand in the European market
4. Shandong Jincheng Pharmaceutical
Headquarters: Jinan, China
Key Offering: Pharmaceutical‑grade API, food‑grade sweetener, and flavor enhancers for processed foods
Shandong Jincheng’s emphasis on process optimization has enabled it to deliver consistent product quality across diverse applications, from cough syrups to baked goods.
Sustainability & Growth Initiatives:
- Implementation of a real‑time monitoring system for raw‑material quality
- Collaboration with a leading Chinese dairy company to supply a natural sweetener for organic milk products
- Expansion of its distribution network into ASEAN countries to capture the rising demand for clean‑label ingredients
3. Jiangsu Tiansheng Pharmaceutical
Headquarters: Nanjing, China
Key Offering: Pharmaceutical‑grade API, food‑grade sweetener, and cosmetic ingredients
Jiangsu Tiansheng’s focus on R&D has resulted in a portfolio of high‑purity products that meet the stringent requirements of both pharmaceutical and cosmetic manufacturers.
Sustainability & Growth Initiatives:
- Launch of a green extraction line that reduces solvent usage by 30%
- Partnership with a leading Chinese cosmetic brand to develop a natural anti‑aging line featuring ammoniated glycyrrhizin
- Strategic expansion into the Indian market through a joint venture with a local nutraceutical company
2. Gansu Yalan Pharmaceutical
Headquarters: Lanzhou, China
Key Offering: Pharmaceutical‑grade API, food‑grade sweetener, and specialty flavor compounds
Gansu Yalan’s investment in advanced purification technologies has allowed it to produce a product with exceptionally low impurity levels, meeting the high standards required for pharmaceutical applications.
Sustainability & Growth Initiatives:
- Adoption of a zero‑waste policy in its manufacturing facilities
- Collaboration with a local agricultural cooperative to ensure sustainable licorice sourcing
- Expansion of its export portfolio to include the Middle East and Africa, targeting a 15% increase in foreign sales by 2029
1. China National Pharmaceutical Group (Sinopharm)
Headquarters: Beijing, China
Key Offering: Pharmaceutical‑grade API, food‑grade sweetener, and functional food additives
Sinopharm’s extensive distribution network and strong regulatory relationships position it to capture a significant share of the global market, especially in emerging economies where demand for natural sweeteners is accelerating.
Sustainability & Growth Initiatives:
- Implementation of a carbon‑neutral production strategy across its manufacturing sites
- Investment in a 250‑t annual capacity plant dedicated to pharmaceutical‑grade ammoniated glycyrrhizin
- Partnership with a leading global pharmaceutical company to co‑develop a new line of anti‑inflammatory cough syrups
Download FREE Sample Report: Global Ammoniated Glycyrrhizin Market – View in Detailed Research Report
Get Full Report Here: Global Ammoniated Glycyrrhizin Market – View in Detailed Research Report
Outlook: The Future of Ammoniated Glycyrrhizin Market
The market is set to evolve around three core dynamics: the clean‑label movement, the expansion of pharmaceutical applications, and the drive for sustainable production practices. Manufacturers that align their supply chains with regulatory requirements and invest in advanced extraction technologies will likely capture the most value.
Key Trends Shaping the Market
- Acceleration of clean‑label initiatives in food & beverage, pushing natural sweeteners into mainstream products.
- Growth of pharmaceutical formulations that leverage the anti‑inflammatory and hepatoprotective properties of ammoniated glycyrrhizin.
- Increased adoption of supercritical CO₂ extraction, enhancing yield and reducing environmental impact.
- Expansion of regional production hubs to mitigate supply‑chain vulnerabilities linked to licorice root cultivation.
Future Trends: Innovation and Market Expansion
Looking ahead, the market will likely see deeper integration of digital traceability, broader applications in cosmeceuticals, and a focus on regional regulatory harmonization. Companies that can navigate the complex regulatory landscape while delivering high‑purity products will be best positioned for long‑term success.
- Top 10 Companies in the Glass Fibers Market (2026): Market Leaders Powering Global Innovation - October 20, 2026
- Top 10 Companies in the Nanomagnetics Materials Market (2026): Market Leaders Driving Innovation - October 20, 2026
- Top 10 Companies in the Global Oxidized Cellulose Market (2026): Market Leaders Driving Innovation in Medical and Industrial Applications - October 20, 2026
